These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7712769)

  • 1. Pediatric critical care physicians' attitudes about guidelines for the use of ribavirin in critically ill children with respiratory syncytial virus pneumonia.
    Zucker AR; Meadow WL
    Crit Care Med; 1995 Apr; 23(4):767-72. PubMed ID: 7712769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatrics academy updates guidelines on ribavirin use. American Academy of Pediatrics.
    Am J Hosp Pharm; 1994 Jan; 51(1):25, 31. PubMed ID: 8135258
    [No Abstract]   [Full Text] [Related]  

  • 3. Ribavirin therapy: implementation of hospital guidelines and effect on usage and cost of therapy.
    Feldstein TJ; Swegarden JL; Atwood GF; Peterson CD
    Pediatrics; 1995 Jul; 96(1 Pt 1):14-7. PubMed ID: 7596703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 1996 Jan; 97(1):137-40. PubMed ID: 8545210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection.
    Ohmit SE; Moler FW; Monto AS; Khan AS
    J Clin Epidemiol; 1996 Sep; 49(9):963-7. PubMed ID: 8780603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients.
    Boeckh M; Englund J; Li Y; Miller C; Cross A; Fernandez H; Kuypers J; Kim H; Gnann J; Whitley R;
    Clin Infect Dis; 2007 Jan; 44(2):245-9. PubMed ID: 17173225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group.
    Moler FW; Steinhart CM; Ohmit SE; Stidham GL
    J Pediatr; 1996 Mar; 128(3):422-8. PubMed ID: 8774517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a large national database for comparative evaluation of the effect of a bronchiolitis/viral pneumonia clinical care guideline on patient outcome and resource utilization.
    Todd J; Bertoch D; Dolan S
    Arch Pediatr Adolesc Med; 2002 Nov; 156(11):1086-90. PubMed ID: 12413334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of RSV pneumonia in adults--evidence of ribavirin effectiveness?
    Dominguez KD; Mercier RC
    Ann Pharmacother; 1999 Jun; 33(6):739-41. PubMed ID: 10410189
    [No Abstract]   [Full Text] [Related]  

  • 11. Red Book recommendations on ribavirin challenged.
    Turner RB
    Pediatrics; 1994 May; 93(5):873; author reply 873-4. PubMed ID: 8165108
    [No Abstract]   [Full Text] [Related]  

  • 12. Red Book recommendations on ribavirin challenged.
    Zucker AR
    Pediatrics; 1994 May; 93(5):872-3; author reply 873-4. PubMed ID: 8165107
    [No Abstract]   [Full Text] [Related]  

  • 13. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database.
    Law BJ; Wang EE; MacDonald N; McDonald J; Dobson S; Boucher F; Langley J; Robinson J; Mitchell I; Stephens D
    Pediatrics; 1997 Mar; 99(3):E7. PubMed ID: 9099772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribavirin. Red Book Committee recommendations questioned.
    Wald ER; Dashefsky B
    Pediatrics; 1994 Apr; 93(4):672-3. PubMed ID: 8134228
    [No Abstract]   [Full Text] [Related]  

  • 15. Qingkailing Injection () for Treatment of Children Pneumonia Induced by Respiratory Syncytial Virus: A Meta-Analysis of Randomized Controlled Trials.
    He S; Li WS; Luo YJ; Ye CL; Zhang ZY
    Chin J Integr Med; 2018 Apr; 24(4):288-295. PubMed ID: 28819777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder.
    Rushton JL; Fant KE; Clark SJ
    Pediatrics; 2004 Jul; 114(1):e23-8. PubMed ID: 15231969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus pneumonia in an AIDS patient.
    van der Ven AJ; Swanink CM; van Crevel R; Bootsma GP; Koopmans PP; Galama JM
    Infection; 1996; 24(5):375-7. PubMed ID: 8923049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosolized ribavirin: the most expensive drug for pneumonia.
    Chemaly RF; Aitken SL; Wolfe CR; Jain R; Boeckh MJ
    Transpl Infect Dis; 2016 Aug; 18(4):634-6. PubMed ID: 27214684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concerned about ribavirin recommendations.
    Pope JF; Besunder JB; Kumar ML; Super DM
    Pediatrics; 1994 Jul; 94(1):132-3. PubMed ID: 8008526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.